- Home
- IRON vs CXW Comparison
IRON vs CXW Comparison
Compare IRON & CXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- CXW
- Stock Information
- Founded
- IRON 2017
- CXW 1983
- Country
- IRON United States
- CXW United States
- Employees
- IRON N/A
- CXW N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- CXW Real Estate Investment Trusts
- Sector
- IRON Health Care
- CXW Real Estate
- Exchange
- IRON Nasdaq
- CXW Nasdaq
- Market Cap
- IRON 1.9B
- CXW 2.0B
- IPO Year
- IRON N/A
- CXW 1997
- Fundamental
- Price
- IRON $52.23
- CXW $20.18
- Analyst Decision
- IRON Strong Buy
- CXW Buy
- Analyst Count
- IRON 10
- CXW 3
- Target Price
- IRON $83.80
- CXW $24.67
- AVG Volume (30 Days)
- IRON 342.1K
- CXW 1.2M
- Earning Date
- IRON 05-08-2025
- CXW 05-07-2025
- Dividend Yield
- IRON N/A
- CXW N/A
- EPS Growth
- IRON N/A
- CXW 5.08
- EPS
- IRON N/A
- CXW 0.62
- Revenue
- IRON N/A
- CXW $1,961,646,000.00
- Revenue This Year
- IRON N/A
- CXW $2.57
- Revenue Next Year
- IRON N/A
- CXW $9.89
- P/E Ratio
- IRON N/A
- CXW $33.08
- Revenue Growth
- IRON N/A
- CXW 3.43
- 52 Week Low
- IRON $25.60
- CXW $10.74
- 52 Week High
- IRON $68.73
- CXW $24.99
- Technical
- Relative Strength Index (RSI)
- IRON 44.88
- CXW 58.35
- Support Level
- IRON $51.57
- CXW $20.05
- Resistance Level
- IRON $53.61
- CXW $20.75
- Average True Range (ATR)
- IRON 2.00
- CXW 0.58
- MACD
- IRON 0.06
- CXW 0.12
- Stochastic Oscillator
- IRON 36.43
- CXW 81.33
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About CXW CoreCivic Inc.
CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.